Carbidopa and levodopa
- Product NDC
- 51862-078
- 11-digit product format
- 518620078
- Labeler code
- 51862
- Product ID
- 51862-078_2cd84ede-15ed-4200-a4b5-e070eddb27e3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Carbidopa and levodopa
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Mayne Pharma Inc.
- Application
- ANDA074260
- Marketing category
- ANDA
- Marketing start
- 2020-04-10
- Marketing end
- 2022-04-30
- Substance
- CARBIDOPA; LEVODOPA
- Active strength
- 10 mg/1; mg/1
- Pharmacologic classes
- Aromatic Amino Acid [EPC],Amino Acids, Aromatic [CS]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51862-078-01 | 51862007801 | 100 TABLET in 1 BOTTLE (51862-078-01) | 100 tablet | 2020-04-10 | 2022-04-30 | No | No | Current |
| 51862-078-05 | 51862007805 | 500 TABLET in 1 BOTTLE (51862-078-05) | 500 tablet | 2020-04-10 | 2022-03-31 | No | No | Current |